$75M Orexigen Asset Sale Gets Approval In Del. Ch. 11 - Law360

06/28/18


$75M Orexigen Asset Sale Gets Approval In Del. Ch. 11
Law360
... pharmaceutical company Orexigen Therapeutics Inc. received court approval Thursday in Delaware for a $75 million sale of its assets to stalking horse bidder Nalpropion Pharmaceuticals, bringing to fruition its hopes for a quick transaction in its ...

[more]